Medication info
Maxaltan Tablet 5/50 mg

Maxaltan Tablet 5/50 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201504321 · Approved 2015.06.30 · Insurance code 652604540

Summary

Main use
Initial treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: This medicine is not recommended for patients with reduced effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: This medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Initial treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used to adequately lower blood pressure in patients with essential hypertension who find it difficult to control blood pressure with amlodipine or losartan monotherapy. It is also used as an initial combination therapy to reach the target blood pressure in patients with stage 2 hypertension. By doing this, it helps effectively control blood pressure and prevent complications related to hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: This medicine is not recommended for patients with reduced effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: This medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication may cause severe harm to the fetus or lead to death if taken during pregnancy, especially in the second and third trimesters; thus, it should be discontinued immediately upon confirmation of pregnancy. Women who could become pregnant are advised not to take this medication, and it is also recommended not to administer it while breastfeeding. Patients with reduced blood volume or those taking diuretics may be at risk for hypotension, so their condition should be well assessed before administration. It should not be used in patients with a history of allergy to any of its components, severely impaired liver function, severe aortic stenosis, or those in shock. Due to the blood pressure-lowering effects, dizziness or drowsiness may occur; therefore, caution is advised when driving or operating dangerous machinery. This medication may enhance the effects of other antihypertensive agents, so it should be used cautiously after consulting with a physician. If unusual symptoms or side effects occur during use, medical professionals should be informed immediately, particularly regarding symptoms of hypotension, renal function decline, or hyperkalemia. Elderly patients and those with reduced renal function may require dose adjustments, so they should follow the guidance of their healthcare provider. Severe hypotension and tachycardia may occur in cases of overdose, so the prescribed dosage must be strictly adhered to, and immediate hospital visits are necessary in case of side effects. The safety and efficacy of this medication have not been established in children, so it is not recommended for pediatric use. This medication should be stored out of reach of children, and it is important to avoid transferring it to other containers to maintain quality.

Side effects

  • Hypotension
  • neonatal cranial formation decrease
  • anuria
  • reversible/irreversible renal failure
  • oligohydramnios
  • fetal limb hypoplasia
  • craniofacial malformation
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth retardation
Show 208 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • vertigo
  • conjunctival hyperemia
  • polyuria
  • fatigue
  • edema
  • lightheadedness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain/loss
  • hypotension
  • vasculitis
  • tension hypertension
  • sensory reduction
  • paresthesia
  • peripheral neuropathy
  • syncope
  • dysgeusia
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urination frequency
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • polymorphic erythema
  • myocardial infarction
  • arrhythmia
  • blood pressure reduction
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • watery stool
  • skin hyperemia
  • maculopapular rash
  • heaviness in the head
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus obstruction
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • palm skin peeling
  • hemolytic phenomenon
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • sinus tachycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscular weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory diminution
  • decreased libido
  • memory impairment
  • migraine
  • irritability
  • panic disorder
  • sleep disturbances
  • tremors
  • bronchitis
  • throat discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • photosensitivity
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • arthralgia
  • conjunctivitis
  • taste disorder
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • urinary tract infection
  • dry cough
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • hepatitis
  • abnormal liver function
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • dysgeusia
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • elevated serum creatinine
  • elevated liver enzymes
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylaxis syndrome
  • excessive peripheral vascular dilation
  • reflex tachycardia
  • systemic hypotension
  • shock
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is recommended to maintain a room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.